Background: The impact of several environmental and genetic factors on diabetes and its complications is well documented but there is an urgent need to understand more about genetic risk factors associated with this disease. The present study was aimed at examining the two single nucleotide polymorphisms (SNP) in intron 8 and exon 9 of the vitamin D receptor (VDR) gene in nephropathic and non-nephropathic type-2 diabetic patients.
Introduction
The frequency of diabetes mellitus is increasing globally and it is expected that this latent disorder will affect 200 million people by 2010 and 300 million by 2025 (Steyn et al. 2008) . Type-2, sometimes referred to as non-insulin dependent diabetes mellitus (NIDDM) or adult-onset diabetes is the most prevalent type of the diabetes (Arababadi et al. 2009a ) and is often caused by decreased insulin production by the pancreas. Current studies showed that several genetic and environmental parameters are associated with type-2 diabetes and its complications (Arababadi et al., 2010; Nathanson & Nystrom, 2008) . The cause of the agents that induce type-2 diabetes and its complications, such as nephropathy, are yet to be clarified. However, it has been suggested that diabetes is an immune dependent disease (Arababadi et al., 2010; Cruz et al., 2008) . For example, in type-2 diabetes, peripheral blood monocytes produce inflammatory cytokines (Giulietti et al., 2007) and serum levels of interferon-γ (IFN-γ) and interlukin-17A (IL-17A) are found to be higher in type-2 diabetes both with and without nephropathy (Arababadi et al., 2009b) . However, it has also been demonstrated that vitamin D and polymorphisms contained within its receptor can affect kidney function in diabetic and non-diabetic patients (Amato et al., 2008 , Baz-Hecht & Goldfine, Martin et al., 2009 . Furthermore, vitamin D has crucial effects on the function of insulin, and may act via a number of pathways which appear to be of importance in the development of type 2 diabetes (Ozfirat & Chowdhury, 2010) . Recent evidence demonstrated that the interaction of 1, 25-dihydroxy vitamin D (the active form of vitamin D) and its receptor (VDR) have a supportive and regulatory impact on the immune system (Fleet, 2008) . The immunoregulatory effects of 1, 25-dihydroxy vitamin D and polymorphisms within VDR on immune system were also demonstrated by several investigators (Evans et al. 2006; Fleet, 2008) .
The association of VDR polymorphisms in immunological disorders such as hepatitis B (Arababadi et al., 2009c) , asthma (Daley et al., 2009) , multiple sclerosis (Arababadi et al., 2009d) and type 1 diabetes (Boraska et al., 2008; Garcia et al., 2007) are well established. Previous studies demonstrated that intron 8 and exon 9 polymorphisms of the VDR gene have an impact on VDR expression (Larcombe et al., 2008) . Therefore, this aim of this study was to investigate the prevalence of two functional single nucleotide polymorphisms (SNP) (Arababadi et al., 2009c) within intron 8 and exon 9 of the VDR gene and correlate this with the occurrence of type-2 diabetes in patients with and without nephropathy.
Material and methods

Subjects:
Peripheral blood samples were collected from 100 type-2 diabetic patients without nephropathy, 100 type-2 diabetic patients showing nephropathic complications and 100 healthy controls. The patient and control groups were selected from within the Rafsanjan population and had similar medical and demographic characteristics including duration of diabetes, sex, age and socio-economical status. The study protocol was approved by the ethical committee of the Rafsanjan University of Medical Sciences, and written informed consent was also obtained from all of participants. Fasting blood sugar, urine albumin level, blood pressure and clinical presentations were assessed three times during a period of 6 months for each patient and the control group. The bias factors such as infections, allergic conditions and smoking were excluded from the study.
Genomic DNA extraction:
To extract genomic DNA, peripheral blood was collected on EDTA and genomic DNA was extracted using a commercial kit (Bioneer, South Korea) according to the manufacture's guide lines. Extracted DNA was aliquoted for each sample and stored at -20°C for further analysis.
Detection of polymorphisms:
VDR gene polymorphisms within intron 8 and exon 9 were analyzed as previously described (Arababadi et al., 2009c) . In brief, primers were designed to flank a known Taq-1 polymorphism carried within exon 9 and a known Apa-1 polymorphism with intron 8 of the VDR gene.
Amplicons were subjected to restriction digestion with the appropriate enzyme and the products separated on an agarose gel. Alleles were scored according to the fragment patterns. Alleles digested by Taq-1 or Apa-1 were scored as T and A alleles respectively whereas alleles not digested by Taq-1 or Apa-1 were scored as t and a alleles respectively.
Statistical analysis:
The differences in genotypes and alleles were analyzed by Pearson ChiSquare test and p values of less than 0.05 were considered significant.
Results
Polymorphisms within the VDR were scored according to PCR-RFLP of exon 8 and introns 9. An example of a typical Taq-1 digestion of exon 8 and how it is scored is shown in figure 1 . Figure 2 shows a typical example of how the Apa-1 polymorphism within intron 9 is scored.
Evaluation of the polymorphism within exon 9 of the VDR gene by Taq-1 restriction digestion showed that the prevalence of T/T genotype was 4 (4%) in type-2 diabetic patients without nephropathy, 9 (9%) in diabetic patients showing nephropathic complications and 18 (18%) in controls (Table 1) . Our results also revealed that the frequency of T/t genotype was 63 (63%), 55 (55%) and 35 (35%) in type-2 diabetic patients without nephropathy, type-2 diabetic patients with nephropathy and controls, respectively ( Table 1 ). The value for the t/t genotype in type-2 diabetic patients without nephropathy was 33 (33%), type-2 diabetic patients showing nephropathy was 36 (36%) and in the control group was 47 (47%) ( Table 1) . Our results demonstrated that the genotype differences were significant in both diabetic groups when compared to the control group (p<0.001 and p=0.012) but the differences between the genotypes of the nephropathic and none-nephropathic patients was not significant (p=0.273) ( Table 1 ). The differences between groups regarding the frequency of T and t alleles were not significant ( Table 1) .
As is shown in table 1, the differences between groups regarding the frequency of the A/A, A/a and a/a genotypes between the three subject groups was not significant. Significant differences were also not seen regarding Apa-1 evaluated alleles in both diabetic patient groups when compared to controls (P=0.236 and p=0.224) as well as between the two patient groups (p=1.000) ( Table 1 ).
There were no significant differences between groups regarding the mean age (P=0.85), gender (P=0.9), duration of diabetes (P=0.1) and socioeconomical status of the participants (P=0.90) ( Table 2 ). The results of the clinical parameters of the different subject groups showed that proteinuria was significantly increased (P=0.002) and estimated GFR was decreased (P<0.001) in nephropathic patients when compared to controls (Table 2) .
Discussion
The impact of vitamin D and its receptor on insulin action and development of type-2 diabetes and its inflammatory complications, such as nephropathy, is in urgent need of additional research to help elucidate the mechanisms of disease progression (Baz-Hecht & Goldfine, Martin, McKnight, Patterson, Sadlier & Maxwell, 2009; Ozfirat & Chowdhury, 2010) . It seems that immune related factors play important roles in the etiology and pathogenesis of type-2 diabetes and associated renal complications (Arababadi et al., 2009b) . Previous studies showed that the polymorphisms within intron 8 and exon 9 of the VDR affect expression of this protein (Arababadi et al., 2009b) . For example, the T allele within exon 9 is associated with decreased expression of VDR (Arababadi et al., 2009b; Larcombe et al., 2008) . In this study, the patient and control groups were matched for duration of diabetes, sex, age and socioeconomical status. Our findings indicated a significant difference between Taq-1 evaluated genotypes of exon 9 within the VDR gene between both diabetic groups and controls. To our knowledge this is the first study which was performed to evaluate the VDR polymorphisms in nephropathic type-2 diabetic patients. However in a study by Oh JY et al., they reported that only Apa-1 genotypes are associated with type-2 diabetes in the American population (Oh & Barrett-Connor, 2002 ) and a link between Bsm-I polymorphisms and onset of the disease were reported by Speer G et al., (Speer G et al., 2001) . Therefore, it may be concluded that Bsm-1 and Apa-1 polymorphisms are important in type-2 diabetes through their effects on VDR gene expression levels. On the other hand, Bid HK et al., that there is no link between polymorphisms in the VDR gene and type-2 diabetes (Bid et al., 2009) . Moreover, other studies also failed to show any link (Valdivielso & Fernandez, 2006) 
. Turkish investigators used
Taq-1 and Apa-1 to evaluate VDR polymorphisms in type-2 diabetic patients (Dilmec et al., 2009 ) and they also failed to find any relationship between these polymorphisms and type-2 diabetes (Dilmec et al., 2009 ).
In addition, Malecki et al., also found no association between Fok-1, Bsm-1, Apa-1 and Taq-1 polymorphisms and the disease (Malecki et al., 2003) . One reason for the discrepancy between our results and these studies could be explained by the genetic differences in populations studied or their exposure to environmental factors. For example, several studies showed that stress is the main reason for inducing type 2 daibetes (Simmons, 2007 , Simmons, 2009 , therefore it is possible that environmental factors impinge on effects of polymorphisms. The different environmental conditions of our study population may give patients carrying the exon 8 T/T genotype a protection against type 2 diabetes. Association of VDR polymorphisms with other type-2 complication also were evaluated by researchers. For example, Cyganek K et al., but they showed that VDR polymorphisms were not associated with type-2 diabetic retinopathy in Polish population (Cyganek et al., 2006) . Based on our study, and results from similar works, it can be concluded that VDR polymorphisms are not associated with nephropathic complications in this type of diabetes because non-nephropathic patients also showed the same polymorphisms; thus, it seems that the VDR polymorphisms are potentially more related to diabetes than nephropathies via an affect on insulin expression or action. Our research team proposes that the role of other VDR polymorphisms in type 2 diabetes and its nephropathy should be evaluated by other researchers, simultaneously to increase the scope and power of the study.
Finally nephropathic complications of type-2 diabetes are very complex and are associated with several environmental and genetic factors which need to be taken in consideration when evaluating different population groups. Clearly larger studies need to be completed using more parameters within the study design to evaluate the independent role of each factor in relationship to the disease. 
